Muscular Dystrophy
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Clinical and genetic features.
|
10825360 |
2000 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.
|
21522182 |
2011 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Muscular dystrophy in dysferlin-deficient mouse models.
|
23473732 |
2013 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Dysferlin and muscular dystrophy.
|
11098285 |
2000 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Dysferlin is a surface membrane protein in skeletal muscle whose deficiency causes distal and proximal, recessively inherited, forms of muscular dystrophy designated Miyoshi myopathy (MM) and limb girdle muscular dystrophy type 2B (LGMD2B), respectively.
|
11532985 |
2001 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Dysferlin and the plasma membrane repair in muscular dystrophy.
|
15066638 |
2004 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Dysferlin-deficient muscular dystrophy features amyloidosis.
|
18306167 |
2008 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Dysferlin is a component of that system and absence of dysferlin causes muscular dystrophy (dysferlinopathy) characterized by adult onset muscle weakness, high serum creatine kinase levels and a prominent inflammatory infiltrate.
|
19286669 |
2009 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Dysferlin is mutated in a group of muscular dystrophies commonly referred to as dysferlinopathies.
|
23558685 |
2013 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Dysferlin mediates membrane tubulation and links T-tubule biogenesis to muscular dystrophy.
|
28104817 |
2017 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Dysferlin is a large transmembrane protein that plays a key role in cell membrane repair and underlies a recessive form of inherited muscular dystrophy.
|
28904177 |
2017 |
Muscular Dystrophy
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
A proteomics screen of human placental microvillous syncytiotrophoblasts (STBs) revealed the expression of dysferlin (DYSF), a plasma membrane repair protein associated with certain muscular dystrophies.
|
17554076 |
2007 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
|
25176504 |
2014 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
LHGDN |
Cytoplasmic localization of dysferlin correlates with fiber regeneration in a subset of muscular dystrophy patients.
|
17897828 |
2008 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
MGD |
Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B.
|
10508505 |
1999 |
Muscular Dystrophy
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Dysferlin mutations cause inherited muscular dystrophy, and dysferlin also shows abnormal plasma membrane expression in other forms of muscular dystrophy.
|
20595382 |
2010 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy.
|
20618995 |
2010 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Furthermore, genetic disruption of the central component (C3) of the complement system ameliorated muscle pathology in dysferlin-deficient mice but had no significant beneficial effect in a genetically distinct model of muscular dystrophy, mdx mice.
|
21060153 |
2010 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
MGD |
Furthermore, genetic disruption of the central component (C3) of the complement system ameliorated muscle pathology in dysferlin-deficient mice but had no significant beneficial effect in a genetically distinct model of muscular dystrophy, mdx mice.
|
21060153 |
2010 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
MGD |
Here we show that dysferlin-null mice maintain a functional dystrophin-glycoprotein complex but nevertheless develop a progressive muscular dystrophy.
|
12736685 |
2003 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
In summary, the restoration of dysferlin in skeletal muscle fibers is sufficient to rescue the MD in Dysf-deficient mice, although its mild overexpression does not appear to functionally enhance membrane repair in other models of MD.
|
19834057 |
2009 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
In the absence of dysferlin, skeletal muscle cells fail to reseal properly after injury, resulting in slow progress of the dysferlinopathy muscular dystrophy (MD).
|
29771357 |
2018 |